SciELO - Scientific Electronic Library Online

 
vol.39 número3Epileptogenesis and the piriform cortex: understanding temporal lobe epilepsy beyond the hippocampusIschemic stroke in a young population: is there a differential approach to risk factors? índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Acta Neurológica Colombiana

versão impressa ISSN 0120-8748versão On-line ISSN 2422-4022

Resumo

CONDE-CARDONA, Giancarlos et al. Quality of Life in Patients with Pompe Disease: Cross-Sectional Study. Acta Neurol Colomb. [online]. 2023, vol.39, n.3, e6.  Epub 03-Nov-2023. ISSN 0120-8748.  https://doi.org/10.22379/anc.v39i3.824.

Introduction:

Pompe disease is a rapidly progressive, multisystemic genetic disease that causes muscle involvement (skeletal, cardiac and smooth), severe hypotonia and difficulty in swallowing. Due to the nature of the disease, the quality of life may be more affected compared to the general population.

Method:

A descriptive cross-sectional study was carried out. A survey-type instrument was designed with questions of sociodemographic characterization and those referring to the disease. To measure Quality of Life, the Medical Outcomes Study 36-Item Short Form (SF-36) questionnaire was applied. A comparison was made between groups with a significance level of 0,05.

Results:

27 surveys of patients from six countries were obtained. The mean age 40.52 years, women 59 %, married 51 %, 63 % active in employment, with a mean age of diagnosis of 30.3 years (SD = 15,557). The dimension with the lowest mean was the Physical Role (10.2; 95 % CI = 1.5 - 21.9), while the one with the highest mean was the Mental Health dimension (65.5; 95 % CI = 56.9 - 74.0). 29.7 % (95 % CI = 11.2 - 48.0) of those surveyed considered they felt in worse health conditions than the previous year.

Discussion:

Low quality of life is evidenced in patients with PD in comparison to the general population described in other studies using the same questionnaire.

Conclusions:

A low quality of life is evidenced in the study individuals where the dimensions related to the physical area were lower.

Palavras-chave : Acid maltase deficiency disease; Glycogen storage disease type II; Quality of life; Rare diseases.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )